X4 Pharmaceuticals, Inc. (XFOR)
4.23
+0.06
(+1.44%)
USD |
NASDAQ |
Aug 27, 16:00
4.22
-0.01
(-0.24%)
After-Hours: 20:00
X4 Pharmaceuticals Total Return Price : 4.23 for Aug. 27, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 27, 2026 | 4.23 |
| August 26, 2026 | 4.17 |
| August 25, 2026 | 4.16 |
| August 24, 2026 | 4.05 |
| August 21, 2026 | 4.04 |
| August 20, 2026 | 4.03 |
| August 19, 2026 | 4.16 |
| August 18, 2026 | 4.21 |
| August 17, 2026 | 4.30 |
| August 14, 2026 | 4.22 |
| August 13, 2026 | 4.29 |
| August 12, 2026 | 4.29 |
| August 11, 2026 | 4.28 |
| August 10, 2026 | 4.25 |
| August 07, 2026 | 4.64 |
| August 06, 2026 | 4.17 |
| August 05, 2026 | 4.15 |
| August 04, 2026 | 4.29 |
| August 03, 2026 | 4.09 |
| July 31, 2026 | 3.98 |
| July 30, 2026 | 4.00 |
| July 29, 2026 | 4.00 |
| July 28, 2026 | 3.93 |
| July 27, 2026 | 3.94 |
| July 24, 2026 | 3.85 |
| Date | Value |
|---|---|
| July 23, 2026 | 3.99 |
| July 22, 2026 | 3.695 |
| July 21, 2026 | 3.69 |
| July 20, 2026 | 3.68 |
| July 17, 2026 | 3.82 |
| July 16, 2026 | 3.83 |
| July 15, 2026 | 3.90 |
| July 14, 2026 | 4.02 |
| July 13, 2026 | 4.05 |
| July 10, 2026 | 4.41 |
| July 09, 2026 | 3.96 |
| July 08, 2026 | 3.96 |
| July 07, 2026 | 3.94 |
| July 06, 2026 | 4.03 |
| July 02, 2026 | 4.13 |
| July 01, 2026 | 4.085 |
| June 30, 2026 | 4.67 |
| June 29, 2026 | 4.23 |
| June 26, 2026 | 4.02 |
| June 25, 2026 | 3.99 |
| June 24, 2026 | 4.09 |
| June 23, 2026 | 4.00 |
| June 22, 2026 | 4.12 |
| June 18, 2026 | 4.22 |
| June 17, 2026 | 4.05 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Sarepta Therapeutics, Inc. | 21.59 |
| Arrowhead Pharmaceuticals, Inc. | 88.59 |
| Oncolytics Biotech, Inc. | 0.85 |
| Sangamo Therapeutics, Inc. | 0.1534 |
| Anixa Biosciences, Inc. | 3.60 |